All AMR Accelerator articles

  • Low-Res__MG_0546
    News

    European capacity for antibiotic R&D requires long-term funding

    2024-09-25T10:13:00Z

    The AMR Accelerator projects have called for long-term investments, stressing the need to preserve the European capacity for antibiotic R&D by sustaining the assets, expertise, and research infrastructures required to develop new treatments for drug-resistant infections.